Common Deficiencies in Recruitment & Retention Plan Highlighted in FDA, EMA and MHRA Inspections
Common Deficiencies in Recruitment & Retention Plan Highlighted in FDA, EMA and MHRA Inspections Clinical research has become increasingly complex, necessitating robust recruitment and retention strategies to ensure the successful completion of clinical trials. Regulatory agencies such as the FDA, EMA, and MHRA routinely inspect these plans and identify common deficiencies that can hinder recruitment…